Recents patents for isolating, delivering and tracking adult stem cells in regenerative medicine

Recent Patents on Drug Delivery and Formulation

Volumn 4, Issue 2, 2010, Pages 105-113

  Fierabracci, Alessandra ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Adult stem cells; Delivery; Isolation; Tracking

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COLONY STIMULATING FACTOR 1; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYOSIN HEAVY CHAIN; NERVE GROWTH FACTOR; SCATTER FACTOR; STAGE SPECIFIC EMBRYO ANTIGEN 1; STEM CELL ANTIGEN 1; STEM CELL FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR PDX 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT STEM CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL TRANSPORT; EXTRACELLULAR MATRIX; FAT DERIVED STEM CELL; HEART STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MATRIX ATTACHMENT REGION; NANOTECHNOLOGY; NEURAL STEM CELL; PANCREAS STEM CELL; PATENT; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; SOMATIC CELL; STEM CELL; STEM CELL EXPANSION; STEM CELL GENE THERAPY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; PATENTS AS TOPIC; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 77954082039     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221110791184980     Document Type: Article

References (68)

1. Kuehnle I, Goodell MA. The therapeutic potential of stem cells from adults. BMJ 2002; 325: 372-6.
2. Korbling E, Estrov Z. Adult stem cells for tissue repair. A new therapeutic concept? N Engl J Med 2003; 349: 570-82.
3. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell 2001; 105: 829-41.
4. Weissman IL. Stem cells: Units of development, units of regeneration and units in evolution. Cell 2000; 100:157-68.
5. Puglisi MA, Giuliani L, Fierabracci A. Identification and characterisation of a novel expandable adult stem/ progenitor cell population in the human exocrine pancreas. J Endocrinol Invest 2008; 31: 563-72.
6. Fierabracci A, Puglisi MA, Giuliani L, Mattarocci S, Gallinella-Muzi M. Identification of an adult stem/progenitor cell-like population in the human thyroid. J Endocrinol 2008; 198: 471-87.
7. Fierabracci A, Caione P, Di Giovine M, Zavaglia D, Bottazzo GF. Identification and characterisation of adult stem/progenitor cells in the human bladder (bladder spheroids): Perspectives of application in pediatric surgery. Pediatr Surg Int 2007; 23: 837-9.
8. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004; 116: 639-48.
9. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000; 97:14720-5.
10. Nunes MC, Roy NS, Keyoung HM, Reitsma MJ, Masek M, Phan TV, et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 2003; 9: 439-47.
11. Maiorana A, Fierabracci A, Cianfarani S. Isolation and characterisation of omental adipose progenitor cells in children: A potential tool to unravel the pathogenesis of metabolic syndrome. Horm Res 2009; 72: 348-58.
12. Segers VFM, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008; 451: 937-42.
13. Reffelmann T, Könemann S, Kloner RA. Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: Putting it in perspective with existing therapy. J Am Coll Cardiol 2009; 53: 305-8.
14. Nesselmann C, Ma N, Bieback K, Wagner W, Ho A, Konttinen YT, et al. Mesenchymal stem cells and cardiac repair. J Cell Mol Med 2008; 12: 1795-810.
15. Menaschè P. Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol 2008; 45: 545-53.
16. Horner PJ, Gage FH. Regenerating the damaged central nervous system. Nature 2000; 407: 963-70.
17. Teng YD, Lavik EB, Qu X, Kooi IP, Jitka Q, David Z, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 2002; 99: 3024-9.
18. Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, et al. Injection of adult neurosphere induces recovery in a chronic model of multiple sclerosis. Nature 2003; 422: 688-94.
19. Alenzi FQ, Alenazi BQ, Ahmad SY, Salem ML, Al-Jabri AA, Wyse RK, et al. The hematopoietic stem cell: Between apoptosis and self-renewal. Yale J Biol Med 2009; 82: 7-18.
20. Hariri, R.J., Stirling, D.I., Moutoh-de Parseval, L.A., Chan, K.W.H. Modulation of stem and progenitor cell differentiation, assays, and uses thereof. US7498171 (2009).
21. Van Zant, G., Watertrat, A. Stem cell regulator, compositions and methods of use. US20090028831 (2009).
22. Brose K, Bland KS, Wang KH, Arnott D, Henzel W, Goodman CS, et al. Slit proteins bind Robo receptors and have an evolutionary conserved role in repulsive axon guidance. Cell 1999; 96: 795-806.
23. Sackstein, R. Cytokine induction of selecting ligands on cells. US20090053198 (2009).
24. Levy, R.J., Burton, D.Y. Compositions and methods for performing reverse gene therapy. US7282489 (2007).
25. Yoon, Y., Cho, H.J. Therapeutic use of CD31 expressing cells. WO2008085221 (2008).
26. Abuljadeyel, I.S. Method of preparing an undifferentiated cell. US7410773 (2008).
27. Kuçi S, Kuçi Z, Latifi-Pupovci H, Niethammer D, Handgretinger R, Schumm M, et al. Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine. Curr Stem Cell Res Ther 2009; 4: 107-17.
28. Sigvardsson M. New light on the biology and developmental potential of hematopoietic stem cells and progenitor cells. J Intern Med 2009; 266: 311-24.
29. Butler MG, Wells C, d'Ardenne AJ. Ultrastructural localization of antigens recognized by the monoclonal antibodies MB1, MB2, MT1, UCHL1, and TAL 1B5. Ultrastruct Pathol 1988; 12: 301-5.
30. Nisitani S, Tsubata T, Honjo T. Lineage marker-negative lymphocyte precursors derived from embryonic stem cells in vitro differentiate into mature lymphocytes in vivo. Int Immunol 1994; 6: 909-16.
31. Bischoff R. Proliferation of muscle satellite cells on intact myofibres in culture. Dev Biol 1986; 115: 129-39.
32. Nakafuku M, Nakamura S. Establishment and characterisation of a multipotential neural cell line that can conditionally generate neurons, astrocytes, and oligodendrocytes in vitro. J Neurosci Res 1995; 41: 153-68.
33. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in hemopoietic cells. Nature 1989; 339: 27-30.
34. Lum, L.G., Lee, R.J. Compositions and methods for stem cell delivery. US75716186 (2009).
35. Lyngbaek S, Schneider M, Hansen JL, Sheikh SP. Cardiac regeneration by resident stem and progenitor cells in the adult heart. Basic Res Cardiol 2007; 102:101-14.
36. Barile L, Messina E, Giacomello A, Marbán E. Endogenous cardiac stem cells. Prog Cardiovasc Dis 2007; 50: 31-48.
37. Yeh ET, Zhang S, Wu HD, Körbling M, Willerson JT, Estrov Z. Transdifferentiation of human peripheral blood CD34+ enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003; 108: 2070-3.
38. Torella D, Ellison GM, Nadal-Ginard B, Indolfi C. Cardiac stem and progenitor cell biology for regenerative medicine. Trends Cardiovas Med 2005; 15: 229-36.
39. Chien, K.R., Caron, L., Nakano, A., Moretti, A. Cardiovascular stem cells, methods for stem cell isolation, and uses thereof. WO2008054819A2 (2008).
40. Cai CL, Liang X, Shi Y, Cghu PH, Pfaff SL, Chen J, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003; 5: 877-89.
41. Stennard FA, Costa MW, Elliot DA, Rankin S, Haast SJP, Lai D, et al. Cardiac T-box factor Tbx20 directly interacts with NKx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol 2003; 262: 206-24.
42. Motoike T, Markham DW, Rossant J, Sato TN. Evidence for novel fate of Flk1+ progenitor: Contribution to muscle lineage. Genesis 2003; 35: 153-9.
43. Edmonton DG, Lyons GE, Martin JF, Olson EN. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 1994; 120:1251-63.
44. Marban, E. Dedifferentiation of adult mammalian cardiomyocytes into cardiac stem cells. WO2008058273 (2008).
45. Fernando, P., Megeney, L. Cardiac stem cell proliferation proteins, fragments thereof and methods of modulating stem cell proliferation and differentiation. US20090042795 (2009).
46. Forby K, Rodriguez G, Hoel B, Narayan J, Gallicano GI. Gp130- mediated Signal Transduction in embryonic stem cells involves activation of Jak and Ras/Mitogen-activated protein. Stem Cells 2005; 23: 530-43.
47. Habener, J.F., Zulewski, H., Abraham, E., Vallejo, M., Faustman, D.L., Thomas, M.K. Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell. US6866843 (2005).
48. Habener, J.F., Abraham, E.J., Zulewski, H., Thomas, M.K., Vallejor, M. Stem cells of the islets of Langherans and their use in treating diabetes mellitus. US7544510 (2009).
49. Yu, J.S., Kabos, P., Ehtesham, M. Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow. US7504100 (2009).
50. Uchida, N., Capela, A. Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations. US7381561 (2008).
51. Weiss, S., Reynolds, B., Hammang, J.P., Baetge, E.E. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny. US5750376 (1998).
52. Weiss, S., Reynolds, B., Hammang, J.P., Baetge, E.E. In vitro growth and proliferation of multipotent neural stem cells and their progeny. US5851832 (1998).
53. Ashwell KWS, Mai JK. Developmental expression of the CD15 epitope in the hippocampus of the mouse. Cell Tissue Res 1997; 289: 17-23.
54. Tamura RN, Rozzo C, Starr L, Chambers J, Reichardt LF, Cooper HM, et al. Epithelial integrin alpha 6 beta 4: Complete primary structure of alpha 6 and variant form of beta 4. J Cell Biol 1990; 111:1593-604.
55. Bauer N, Fonseca Av, Florek M, Freund D, Jászai J, Bornhäuser M, et al. New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cell Tissues Organs 2008; 188: 127-38.
56. Yoshimura, K., Nagase, T., Matsumoto, D., Shigeura, T. Fat- derived neural crest cells. WO2008018190 (2008).
57. Ying, J.Y., Leck, K.J., Wan, A.C.A. Three-dimensional reconstituted extracellular matrices as scaffolds for tissue engineering. US20090035855 (2009).
58. Kotov, N.A., Cortiella, J., Nichols, J.E. Cell culture well-plates having inverted colloidal crystal scaffolds. US20090041825 (2009).
59. Yudoh, Z. Biomaterials for regenerative medicine. EP1935438A1 (2008).
60. Mcallister, T.N., L'heureux, N. Tissue engineered cellular sheets, methods of making and use thereof. US7504258 (2009).
61. Arbab AS, Janic B, Hailer J, Pawelczyk E, Liu W, Frank JA. in vivo Cellular imaging for translational medical research. Curr Med Imaging Rev 2009, 5: 18-38.
62. Tung C.-H., Zeng Q., Shah K., Kim D.-E., Schellingerhout D., Weissleder R. In vivo imaging of ß-Galactosidase activity using far red fluorescent switch. Cancer Res 2004; 64: 1579-83.
63. Heckl S, Pipkorn R, Nägele T, Küker W, Voight K. Molecular imaging: Bridging the gap between neuroradiology and neurohistology. Histol Histopathol 2004; 19: 651-68.
64. Ferreira L, Karp JM, Nobre L, Langer R. New opportunities: The use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell 2008; 3: 136-46.
65. Cohen, I.S., Rosen, A. B., Brink, P. R., Gaudette, G., Rosen, M.R., Robinson, R.B. Quantum dot labeled stem cells for use in providing pacemaker function. US20090062876 (2009).
66. Lee, J.H., Seo, W.-S., Dai, H., Liu, Z., Sherlock, S.P. Multifunc- tional metal-graphite nanocrystals. US20080213189 (2008).
67. Kundra, V. Compositions and methods involving truncated recombinant seven g-protein coupled receptors. WO2008085564 (2008).
68. Hill SJ. G-protein-coupled receptors: Past, present and future. Br J Pharmacol 2006; 147 (Suppl 1): S27-S37.